These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12004461)

  • 1. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Fujimura A
    J Clin Pharmacol; 1999 Oct; 39(10):1070-6. PubMed ID: 10516942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
    Yu HY
    Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.
    Kodama Y; Kuranari M; Kodama H; Zaizen T; Yukawa E; Fujii I; Takeyama M
    J Pharm Pharmacol; 1996 Oct; 48(10):1068-72. PubMed ID: 8953510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.
    Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M
    Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding parameters of valproic acid to serum protein in healthy adults at steady state.
    Kodama Y; Koike Y; Kimoto H; Yasunaga F; Takeyama M; Teraoka I; Fujii I
    Ther Drug Monit; 1992 Feb; 14(1):55-60. PubMed ID: 1546390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
    Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
    Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.
    Heo G; Kim SH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):758-764. PubMed ID: 28626875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
    Dutta S; Faught E; Limdi NA
    J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.
    Kodama H; Kodama Y; Itokazu N; Shinozawa S; Kanemaru R; Sugimoto T
    J Clin Pharm Ther; 2001 Jun; 26(3):175-9. PubMed ID: 11422600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
    J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.